Age Ayurveda Nighantu

Udumbara

Ficus racemosa Linn.

Udumbara (Ficus racemosa Linn.) is a plant used in Ayurveda, from the Moraceae family. Listed in the Ayurvedic Pharmacopoeia of India (API). An absence here means we could not identify the source, not that no work exists.

Key facts
Botanical nameFicus racemosa Linn.
FamilyMoraceae · other entries in this family
OrderRosales
Pharmacopoeia statusListed in the Ayurvedic Pharmacopoeia of India (API). Not included in WHO monographs on selected medicinal plants as of 2025. Recognized in AYUSH systems of India.
Taxon identifiersGBIF 5361904 · Wikidata Q713794 · NCBI Taxonomy 100569

Names and identification

LanguageName
EnglishUdumbara
Latin/BotanicalFicus racemosa Linn.

Key Phytochemical Constituents

How does it work?

  • Antidiabetic action via beta-sitosterol-mediated enhancement of insulin secretion and improvement of peripheral glucose uptake
  • Hepatoprotective effect through bergenin-mediated reduction of liver enzyme levels and suppression of oxidative stress biomarkers
  • Anti-diarrheal activity through tannin-mediated astringent effects on intestinal mucosa and reduction of intestinal motility
  • Antioxidant action via free radical scavenging by phenolics, flavonoids and bergenin

Which traditional uses are supported by research?

  • Antidiabetic activity validated in alloxan and STZ-induced diabetic animal models with significant blood glucose reduction
  • Anti-diarrheal properties confirmed through castor oil-induced diarrhea models showing significant reduction in frequency and volume
  • Wound healing activity demonstrated in excision and incision wound models with improved collagen deposition and epithelialization
  • Gastroprotective activity validated against aspirin and ethanol-induced gastric ulcer models

What do recent clinical trials show?

3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Toxicity studies in rodent models show no significant adverse effects at doses up to 2000 mg/kg body weight (acute oral toxicity)
  • Latex may cause contact dermatitis in sensitive individuals; internal use of latex should be supervised due to potential purgative effects at high doses

Dosage forms and preparation

Dosage Forms: Churna (powder), Kwatha (decoction), Kashaya (astringent wash), Capsule, Tablet, Svarasa (latex/juice), Lepa (paste)

Standard Dosage: 3-6 g bark powder twice daily; 50-100 mL decoction twice daily; latex: 5-10 drops with honey

Bioavailability: Ficusin and psoralen (furocoumarins) have moderate oral bioavailability (~25-35%). Leucocyanidin and other condensed tannins are poorly absorbed systemically but exert potent local astringent effects on mucosa. beta-Sitosterol has moderate absorption (~10-15%) enhanced by lipid co-administration. Latex proteases (ficin-like enzymes) are active topically but denatured in GI tract.

Optimal Timing: Before meals for GI astringent action; after meals for general tonic; external application as needed

Standardized Extract: Bark extract standardized to >12% total tannins (as tannic acid equivalent); >0.3% beta-sitosterol by HPLC; >0.1% psoralen by HPLC

Shelf Life: Bark powder: 18-24 months; Capsules/Tablets: 24-36 months; Decoction: prepare fresh; Latex: 6-12 months (refrigerated)

Storage: Bark powder in airtight containers at 15-25 deg C, protected from moisture and insects. Latex stored in amber glass at 2-8 deg C with preservative (0.1% sodium benzoate).

Marker Compounds: Ficusin, Psoralen, Bergapten, Leucocyanidin, beta-Sitosterol, Stigmasterol, Gallic acid, Ellagic acid, Lupeol, Ficin

Extraction Methods

  • Aqueous decoction of bark
  • Hydroethanolic extraction (50-70% ethanol)
  • Cold water maceration for mucilaginous fraction
  • Latex collection (scoring bark)
  • Methanol extraction for furocoumarin enrichment

Synergistic Combinations

  • Ashoka (Saraca asoca) - synergistic uterine tonic for menorrhagia
  • Lodhra (Symplocos racemosa) - astringent synergy for gynecological conditions
  • Nyagrodha (Ficus benghalensis) - Panchavalkal combination (five bark formula)
  • Gular bark in Panchvalkal with Ashvattha, Plaksha, Parisha

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Other clinical studies and reviews4

  1. Rani A, Zia-Ul-Sabah, Tabassum F and others. 2024. Molecular interplay between phytoconstituents of Ficus Racemosa and neurodegenerative diseasesThe European journal of neuroscience. PMID 38217338 · doi:10.1111/ejn.16250
  2. Febriyanti RM, Levita J, Diantini A. 2024. Immunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based ReviewDrug design, development and therapy. PMID 38415194 · doi:10.2147/DDDT.S442566
  3. Yadav RK, Nandy BC, Maity S and others. 2015. Phytochemistry, pharmacology, toxicology, and clinical trial of Ficus racemosaPharmacognosy reviews. PMID 26009696 · doi:10.4103/0973-7847.156356
  4. Ahmed F, Urooj A. 2010. Traditional uses, medicinal properties, and phytopharmacology of Ficus racemosa: a reviewPharmaceutical biology. PMID 20645741 · doi:10.3109/13880200903241861

Laboratory and animal studies8

  1. Dong Y, Segar ST, Weng Q. 2026. figsimR: An R Package for Simulating Fig-Wasp Community DynamicsEcology and evolution. PMID 42483029 · doi:10.1002/ece3.74018
  2. Swargiary A, Daimari M, Verma AK. 2025. Screening of antihyperglycemic and cytotoxic properties of Ficus racemosa L. Fruit extractIn silico pharmacology. PMID 40727492 · doi:10.1007/s40203-025-00397-3
  3. Hossain MU, Rahman ABZN, Hossain MS and others. 2025. Harnessing animal model and computational experiments to discover antidiabetic compounds in Ficus racemosaBMC complementary medicine and therapies. PMID 40604816 · doi:10.1186/s12906-025-04845-7
  4. Rani A, Sharma PB, Bhatia S and others. 2024. Comprehensive study on pharmacognostic, pharmacological, and toxicological features of Ficus racemosa in Alzheimer's disease using GC-MS and molecular docking analysesToxicology research. PMID 38957785 · doi:10.1093/toxres/tfae098
  5. Singh P, Ranjan R, Tripathi R and others. 2023. GC-MS and NMR spectroscopy based metabolite profiling of Panchvalkal kwath (polyherbal formulation)Natural product research. PMID 34661480 · doi:10.1080/14786419.2021.1990919
  6. Ahmed F, Urooj A, Karim AA. 2013. Protective effects of Ficus racemosa stem bark against doxorubucin-induced renal and testicular toxicityPharmacognosy magazine. PMID 23772108 · doi:10.4103/0973-1296.111265
  7. Bhatta R, Saravanan M, Baruah L and others. 2012. Nutrient content, in vitro ruminal fermentation characteristics and methane reduction potential of tropical tannin-containing leavesJournal of the science of food and agriculture. PMID 22522493 · doi:10.1002/jsfa.5703
  8. Ahmed F, Chandra JN, Manjunath S. 2011. Acetylcholine and memory-enhancing activity of Ficus racemosa barkPharmacognosy research. PMID 22224047 · doi:10.4103/0974-8490.89744

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.